- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Zimmer Biomet Holdings Inc (ZBH)
Zimmer Biomet Holdings Inc stock price live, this page displays NYSE ZBH stock exchange data. View the ZBH premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Zimmer Biomet Holdings Inc real time stock price chart below.
What Is the Zimmer Biomet Holdings Inc Stock Price Today?
The Zimmer Biomet Holdings Inc stock price today is 96.87.
What Is the Stock Symbol for Zimmer Biomet Holdings Inc?
The stock symbol for Zimmer Biomet Holdings Inc is ""ZBH.""
What Stock Exchange Does Zimmer Biomet Holdings Inc Trade On?
Zimmer Biomet Holdings Inc is listed and trades on the NYSE stock exchange.
Is Zimmer Biomet Holdings Inc a Good Stock to Buy?
Determining whether Zimmer Biomet Holdings Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ZBH quote. (ISIN: US98956P1021)
What Is the Zimmer Biomet Holdings Inc Stock Price Today?
The Zimmer Biomet Holdings Inc stock price today is 96.87.
What Is the Stock Symbol for Zimmer Biomet Holdings Inc?
The stock symbol for Zimmer Biomet Holdings Inc is ""ZBH.""
What Stock Exchange Does Zimmer Biomet Holdings Inc Trade On?
Zimmer Biomet Holdings Inc is listed and trades on the NYSE stock exchange.
Is Zimmer Biomet Holdings Inc a Good Stock to Buy?
Determining whether Zimmer Biomet Holdings Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ZBH quote. (ISIN: US98956P1021)
Currency in USD
96.87
-0.46(-0.47%)
Closed·
After Hours
96.870.00(0.00%)
·
Fair Value
An estimate of a Zimmer Biomet's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
96.78
97.77
52 wk Range
89.22
116.71
ZBH Scorecard
Full Analysis
Management has been aggressively buying back shares
Earnings results expected in 14 days
More Info
Fair Value
An estimate of a Zimmer Biomet's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
96.7897.77
52 wk Range
89.22116.71
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.99%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.99%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ZBH Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Zimmer Biomet's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
108.44
Upside
+11.94%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has maintained dividend payments for 14 consecutive years
- Zimmer Hldgs receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Zimmer Hldgs receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Zimmer Biomet Holdings Inc Company Profile
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products. The company’s products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Zimmer Biomet Holdings Inc SWOT Analysis
Orthopedic Innovato | Zimmer Biomet navigates challenges while maintaining mid-single-digit growth, leveraging a robust product pipeline including ROSA Shoulder and new knee implants |
Financial Resilience | Despite ERP implementation hurdles, ZBH reports $1.82B Q3 sales. Analysts set price targets ranging from $101 to $140, with an average around $125 |
Strategic Expansion | Explore Zimmer Biomet's $1.1B acquisition of Paragon 28, positioning the company in the $5B Foot & Ankle Orthopedics market for diversified growth |
Future Prospects | Delve into ZBH's Long Range Plan targeting mid-single-digit revenue growth and EPS growth at 1.5x revenue rate, amid market challenges and opportunities |
Zimmer Biomet Holdings Inc Earnings Call Summary for Q1/2025
- Q1 2025 EPS of $1.81 beat expectations, but stock fell 8.12% to $102.38 amid investor concerns over YoY EPS decline
- Revenue grew 1.1% YoY to $1.91B; company reaffirmed 3-5% organic constant currency revenue growth guidance for 2025
- Anticipated $60-80M tariff headwinds in 2025; management confident in offsetting EPS dilution from tariffs and acquisitions
- ASC market growth and Paragon 28 acquisition highlighted as key revenue drivers; inventory management remains a challenge
- InvestingPro analysis suggests stock undervaluation with $18.64B market cap and 10.2x EV/EBITDA ratio
Last Updated: 05/05/2025, 14:58
Read Full TranscriptCompare ZBH to Peers and Sector
Metrics to compare | ZBH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipZBHPeersSector | |
|---|---|---|---|---|
P/E Ratio | 21.0x | −13.7x | −0.5x | |
PEG Ratio | −9.04 | 0.00 | 0.00 | |
Price/Book | 1.5x | 2.9x | 2.6x | |
Price / LTM Sales | 2.5x | 2.7x | 3.2x | |
Upside (Analyst Target) | 6.9% | 86.8% | 41.9% | |
Fair Value Upside | Unlock | −2.2% | 4.3% | Unlock |
Analyst Ratings
11 Buy
16 Hold
2 Sell
Ratings:
29 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 108.44
(+11.94% Upside)
Earnings
Latest Release
May 05, 2025
EPS / Forecast
1.81 / 1.77
Revenue / Forecast
1.91B / 1.89B
People Also Watch
FAQ
What Stock Exchange Does Zimmer Biomet Trade On?
Zimmer Biomet is listed and trades on the New York Stock Exchange stock exchange.
What Is the Stock Symbol for Zimmer Biomet?
The stock symbol for Zimmer Biomet is "ZBH."
What Is the Zimmer Biomet Market Cap?
As of today, Zimmer Biomet market cap is 19.22B.
What Is Zimmer Biomet's Earnings Per Share (TTM)?
The Zimmer Biomet EPS (TTM) is 4.53.
When Is the Next Zimmer Biomet Earnings Date?
Zimmer Biomet will release its next earnings report on 06 Aug 2025.
From a Technical Analysis Perspective, Is ZBH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Zimmer Biomet Stock Split?
Zimmer Biomet has split 0 times.
How Many Employees Does Zimmer Biomet Have?
Zimmer Biomet has 17000 employees.
What is the current trading status of Zimmer Biomet (ZBH)?
As of 24 Jul 2025, Zimmer Biomet (ZBH) is trading at a price of 96.87, with a previous close of 97.33. The stock has fluctuated within a day range of 96.78 to 97.77, while its 52-week range spans from 89.22 to 116.71.
What Is Zimmer Biomet (ZBH) Price Target According to Analysts?
The average 12-month price target for Zimmer Biomet is USD108.44, with a high estimate of USD135 and a low estimate of USD91. 11 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Neutral. The stock has an +11.94% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.